Lifestyle Changes for Stress and High Blood Pressure in Dementia Caregivers
(MIM-DASH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist African American women who care for family members with Alzheimer's and have high blood pressure (hypertension). The study examines how lifestyle changes, such as stress management, increased consumption of fruits and vegetables, and regular exercise, can improve health outcomes. Participants will attend eight weekly sessions via telehealth to learn stress and diet management through caregiver training. Women who self-identify as Black or African American, provide unpaid care for someone with dementia for at least 10 hours a week, and take medication for high blood pressure may be suitable candidates. As an unphased trial, this study offers a unique opportunity to explore lifestyle changes that could enhance well-being and the caregiving experience.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, since it includes participants who are already on antihypertensive medication, it seems likely that you can continue your current treatment.
What prior data suggests that these lifestyle changes are safe for managing stress and high blood pressure in dementia caregivers?
Research shows that the MIM-DASH program is practical and well-received by African Americans with high blood pressure and mild memory issues. Earlier studies have shown that this program holds promise in reducing stress and enhancing the quality of life for caregivers. Participants generally handled the treatment well, with no major side effects reported. This suggests the program is safe, particularly for those managing stress and high blood pressure.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores unique lifestyle interventions for managing stress and high blood pressure among dementia caregivers. Unlike standard medication-based treatments, this trial emphasizes non-pharmacological approaches, such as the MIM-DASH program, which combines dietary guidance and stress management techniques delivered through convenient telehealth sessions. This approach not only aims to improve caregivers' physical health but also their mental well-being, offering a holistic alternative to traditional care. By focusing on caregiver training and support, researchers hope to uncover effective methods to alleviate the burdens faced by those caring for loved ones with dementia.
What evidence suggests that this trial's treatments could be effective for stress and high blood pressure in dementia caregivers?
Research has shown that lifestyle changes such as managing stress, reducing salt intake, eating more fruits and vegetables, and exercising regularly can help control high blood pressure. In this trial, participants may join the MIM-DASH program, which includes these changes and has proven helpful for African American women caring for family members with dementia. This program emphasizes building stress resilience—the body's ability to cope with stress—to reduce stress and improve heart health. Evidence supports that the DASH diet can lower blood pressure, making it a key component of this program. Overall, the MIM-DASH program appears promising for improving health in this group. Another group in this trial will receive Caregiver Training using Alzheimer's Association resources, focusing on topics like healthy living and dementia-related behavior.12567
Who Is on the Research Team?
Kathy Wright, PhD
Principal Investigator
Ohio State University
Are You a Good Fit for This Trial?
This trial is for African American women over 40 who care unpaid for a family member with Alzheimer's or related dementias, work at least 10 hours per week in caregiving, have high blood pressure treated with medication, and can access the internet. It excludes those planning to move soon, with resistant hypertension, or actively doing mindfulness/yoga.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the MIM DASH intervention or Caregiver Training in 8 weekly 1-hour group sessions via telehealth
Follow-up
Participants receive bi-monthly coaching calls after completion of the 8-week intervention
Long-term Follow-up
Participants are monitored for changes in blood pressure, stress management practices, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Caregiver Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator